Blue Mountain and Zifo, Global Leaders in Life Sciences Pharmaceutical Manufacturing, Announce Strategic Partnership to Revolutionize Enterprise Asset Management
27 juin 2024 09h00 HE
|
Blue Mountain
Blue Mountain and Zifo announce a partnership to enhance efficiency and innovation in the life sciences sector, offering advanced solutions for GMP.
Forbion Strengthens US Presence, Hiring Biotech Industry Leader and Opening Boston Office
27 juin 2024 07h00 HE
|
Forbion
Josh Brumm, previously CEO of Dyne Therapeutics, appointed as General Partner at Forbion. Brumm to be located at Forbion's new Boston office.
Jura Health Welcomed by Colorado Medicaid as an Approved Provider for Testing for Suspected Rare Diseases
20 juin 2024 11h55 HE
|
Innosphere Ventures
Denver, Colorado, June 20, 2024 (GLOBE NEWSWIRE) -- Jura Health, an Innosphere Ventures client company, committed to health equity for rare disease patients and their families, is pleased to...
API and the University of Alberta Break Ground in Edmonton on Canada’s Largest Manufacturing Facility for Critical Medicines
20 juin 2024 10h30 HE
|
Applied Pharmaceutical Innovation (API)
Construction is set to begin on a pharmaceutical manufacturing facility that will provide Canadians with access to a secure supply of critical medicines.
Forbion announces first close of its new BioEconomy Fund I: backing biotech-enabled companies aiming to impact the future of our planet
20 juin 2024 01h25 HE
|
Forbion
Forbion announces the first close of its latest fund, Forbion BioEconomy Fund I (“Forbion BioEconomy"), at €75 million.
Avextra AG and SynQube GmbH announce a Strategic Partnership in Drug Development with Cannabinoids and other Psychotropic Substances
20 juin 2024 01h00 HE
|
Avextra AG
Avextra, the leading European vertically-integrated manufacturer and developer of cannabis-based medicines, is expanding its pharmaceutical development capabilities. Behind SynQube GmbH are the two...
Avextra und SynQube GmbH geben eine strategische Partnerschaft in der Arzneimittelentwicklung mit Cannabinoiden und anderen psychotropen Substanzen bekannt
20 juin 2024 01h00 HE
|
Avextra AG
Avextra, der führende europäische vertikal integrierte Hersteller und Entwickler von Medikamenten auf Cannabisbasis, erweitert nach Abschluss seiner Finanzierungsrunde im ersten Quartal 2024 seine...
Avextra AG and SynQube GmbH announce a Strategic Partnership in Drug Development with Cannabinoids and other Psychotropic Substances
20 juin 2024 01h00 HE
|
Avextra AG
Avextra, the leading European vertically-integrated manufacturer and developer of cannabis-based medicines is expanding its pharmaceutical development capabilities. Behind SynQube GmbH are the two...
Solomon Partners Expands Healthcare Group with Hiring of Whit Knier as a Partner
17 juin 2024 10h30 HE
|
Solomon Partners
NEW YORK, June 17, 2024 (GLOBE NEWSWIRE) -- Solomon Partners, a leading financial advisory firm, has hired Whit Knier as a Partner. He will be working within the Healthcare Services group led by...
Definitive Healthcare Wins 2024 Databricks Healthcare and Life Sciences Partner of the Year Award
11 juin 2024 09h15 HE
|
Definitive Healthcare Corp.
FRAMINGHAM, Mass., June 11, 2024 (GLOBE NEWSWIRE) -- Definitive Healthcare (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced it has been named the 2024...